InMed Pharmaceuticals Financial Overview
InMed Pharmaceuticals's market cap is currently $3.51M. The company's EPS TTM is $-0.437; its P/E ratio is -0.18; InMed Pharmaceuticals is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
